Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer

We report unexpectedly high efficacy of temsirolimus as third-line treatment in a patient with metastatic chromophobe renal cell carcinoma. After failure of two sequentially administered tyrosine kinase inhibitors, treatment with temsirolimus resulted in a prolonged partial remission of 14 months, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zardavas, Dimitrios, Meisel, Alexander, Samaras, Panagiotis, Knuth, Alexander, Renner, Christoph, Pestalozzi, Bernhard C., Stenner-Liewen, Frank
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: January 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082484/
https://www.ncbi.nlm.nih.gov/pubmed/21526001
http://dx.doi.org/10.1159/000323804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082484/
https://www.ncbi.nlm.nih.gov/pubmed/21526001
http://dx.doi.org/10.1159/000323804

Ejemplares similares